HCPCS code J0561: Penicillin G benzathine billing guide

Key Takeaways

HCPCS code J0561 covers injection of penicillin G benzathine per 100,000 units – the primary code for billing Bicillin L-A under Medicare Part B

Billing units are calculated by dividing the dose in units by 100,000 – a 1.2 million unit Bicillin L-A dose = 12 units of J0561

Medicare reimburses J0561 at ASP+6% under Part B drug coverage – rates update quarterly and must be verified against the current CMS ASP pricing file

Pabau’s claims management software helps practices track J-code billing, flag unit calculation errors, and submit cleaner claims across Medicare and Medicaid payers

J0561 is a HCPCS Level II code maintained by the Centers for Medicare and Medicaid Services (CMS). It represents one billable unit of 100,000 units of penicillin G benzathine, administered by injection. Unlike CPT codes, HCPCS J-codes cover the drug itself – not the administration act.

J0561 covers the drug component only. Practices bill separately for the injection administration using CPT 96372. Both codes typically appear on the same claim for an outpatient IM injection visit.

How to calculate billing units for J0561

The per-100,000-unit increment catches more billers than any other aspect of J0561. Every dose must be converted to a unit count before submission. The formula is simple: divide the prescribed dose (in units) by 100,000. The result is the number of J0561 units to report on the claim.

The 1.2 million unit dose (12 units) is the most common billing scenario – it covers standard adult syphilis treatment and streptococcal prophylaxis. The 2.4 million unit dose (24 units) applies to late latent syphilis and neurosyphilis prophylaxis protocols. Source: Maryland DHMH local health department billing manual.

Billing the wrong unit count is the top denial trigger for J0561 claims. A single-unit submission for a 2.4M dose underpays the provider by a factor of 24. Always verify the units field before claim submission. Practices using structured clinical documentation workflows can build the dose-to-unit conversion into their intake process to prevent this error at the source.

J0561 Medicare reimbursement and fee schedule

Medicare pays for J0561 under Part B drug coverage using Average Sales Price (ASP) methodology. The payment rate is ASP plus 6%, applied per unit of 100,000 penicillin G benzathine units. According to CMS Part B drug payment policy under 42 CFR 414.904, ASP-based rates update each calendar quarter as manufacturers report new pricing data.

Because rates change quarterly, any specific dollar figure in a reference guide may be stale within 90 days. Always verify the current allowable against the CMS ASP Drug Pricing Files before quoting a rate to a payer or patient. The CMS Physician Fee Schedule lookup tool allows practices to search current payment allowables by HCPCS code.

2025 fee schedule update

The 2025 J0561 fee schedule reflects quarterly ASP updates from CMS. At publication, the per-unit Medicare allowable for HCPCS Code J0561 is subject to the most recent Q2 2025 ASP filing. Practices should pull the current rate directly from the CMS HCPCS quarterly update page each quarter rather than relying on third-party rate tables, which may lag the official release by weeks.

For a 1.2 million unit dose (12 units), multiply the per-unit ASP+6% allowable by 12 to determine the expected Medicare reimbursement. For a 2.4 million unit dose, multiply by 24. These calculations apply to the drug component only. The CPT 96372 administration fee is calculated separately using the Medicare Physician Fee Schedule RVU lookup.

Diagnosis codes commonly paired with J0561

Most payers require a supporting ICD-10-CM diagnosis code on every J0561 claim. Three clinical categories account for the majority of J0561 billing scenarios. According to the Maryland DHMH billing manual and standard clinical coding practice, payer-specific coverage policies vary – what one payer accepts, another may deny. Confirm medical necessity requirements with each payer before assuming a pairing is universally covered.

Practices operating sexual health clinics bill A50-A53 range codes most frequently with J0561. The syphilis ICD-10 codes from A50 (congenital) through A53 (other and unspecified syphilis) are the primary medical necessity anchors for penicillin G benzathine injection billing. For ICD-10 coding context in other clinical categories, each specialty should verify payer-specific coverage criteria separately.

Administration CPT code: Billing J0561 with CPT 96372

J0561 reimburses the drug only. The intramuscular injection itself requires a separate administration code. CPT 96372 (therapeutic, prophylactic, or diagnostic injection, subcutaneous or intramuscular) is the standard code for the administration component of a Bicillin L-A injection.

• J0561 – covers penicillin G benzathine drug cost, billed per 100,000 units
• CPT 96372 – covers the intramuscular injection administration service
• Both codes appear on the same claim line for an outpatient IM injection visit
• Some payers bundle CPT 96372 into the E/M visit if a physician evaluation occurs on the same day – verify payer-specific bundling policies before assuming 96372 is always separately reimbursable
• CPT 96372 cannot be billed when the injection is self-administered or administered during a separately billable infusion

For practices managing high volumes of injection-based services, prescription management workflows that log drug lot numbers, doses, and administration routes at the point of care make it significantly easier to reconstruct claim detail if a payer requests documentation review. That documentation anchor is what protects 96372 when a bundling audit occurs.

NDC reporting requirements for J0561

Medicaid requires providers to report the National Drug Code (NDC) on claims for J-code drugs including J0561. Without an NDC, Medicaid claims are rejected in most states. The NDC must match the actual product dispensed – not just the reference NDC for the code family.

Bicillin L-A NDC numbers vary by vial size and manufacturing lot. Common formats include the 1.2 million unit prefilled syringe (2 ml) and 2.4 million unit prefilled syringe (4 ml). Always verify the current NDC against the product’s package labeling before claim submission, as manufacturing changes can alter NDC assignments. A detailed HCPCS Level II code reference from AAPC provides NDC crosswalk data that can support the verification process.

NDC reporting format on Medicaid claims follows the 11-digit format (5-4-2 or 5-3-3 split depending on state). The qualifier “N4” precedes the NDC on CMS-1500 claims. Missing or misformatted NDC submissions are among the top three denial reasons for J0561 Medicaid claims. Practices using digital intake and clinical documentation forms can capture the administered product’s NDC at the point of care and carry it automatically through to claim generation.

Related HCPCS codes: J0558, J0560, and J0570

Several adjacent J-codes cover penicillin G benzathine formulations at different unit increments or in combination products. Using the wrong code for the dispensed product is a billing error, not just a clerical one – payers cross-reference billed HCPCS codes against NDC records, and mismatches trigger audits. The table below clarifies which code applies to each formulation.

The critical distinction is J0558 versus J0561. Bicillin C-R (the combination product with procaine penicillin) is billed under J0558 and must never be coded as J0561. Bicillin L-A (benzathine penicillin only, without procaine) is correctly billed under J0561. Confusing these two codes – which have different clinical applications and different coverage policies for syphilis treatment – is a compliance risk. For additional procedure code billing references in other clinical areas, the same payer-verification discipline applies.

Billing J0561 during the Bicillin shortage: Extencilline coverage

Bicillin L-A has been on the FDA drug shortage list for several years, driving some states to authorize temporary coverage of imported alternatives under J0561. The most clinically significant alternative is Extencilline (benzathine benzylpenicillin), a Sandoz-manufactured product not FDA-approved for the US market but authorized for emergency import by state Medicaid agencies during shortage periods.

Coverage is state-specific and time-limited. North Carolina Medicaid (NCDHHS) and South Carolina DHHS issued temporary coverage bulletins authorizing Extencilline billing under J0561. Medi-Cal in California issued similar guidance. Practices should consult their state Medicaid agency’s most current bulletin before billing Extencilline under J0561, as coverage authorizations can expire or change without notice.

• Bill Extencilline under J0561 using the same per-100,000-unit calculation as Bicillin L-A
• Report the Extencilline NDC on Medicaid claims (different from Bicillin L-A NDCs)
• Some states require a modifier or prior authorization for shortage-related alternatives
• Medicare Part B coverage for imported Extencilline may differ from Medicaid – verify separately
• Document the shortage and the substitution in the patient record to support claim defense if audited

The FDA drug shortage database is the authoritative source for current Bicillin L-A availability. Practices managing shortage-related substitutions alongside their regular medical office compliance obligations should build a documentation protocol that captures the substitution rationale at the time of administration, not retroactively.

Documentation requirements and common denial reasons

Clean J0561 claims share a consistent documentation pattern. Missing any of the elements below is a predictable denial – not an edge case.

• Drug administered: document the exact product name (Bicillin L-A or Extencilline), vial size, lot number, and NDC
• Dose in units: record the prescribed dose in units (e.g., 1,200,000 units) – not just “Bicillin 1.2M”
• Route and site: confirm intramuscular administration and injection site in the clinical note
• Diagnosis: link the ICD-10 code to a documented clinical indication in the record
• Prescriber order: the administering order must be in the chart, signed and dated before administration
• Units billed match dose: billing units on the claim must equal dose in units divided by 100,000

The most common denial reasons for HCPCS Code J0561 claims fall into three categories. Wrong unit count (billing 1 or 2 units for a 12-unit dose) is the most frequent. Missing or misformatted NDC on Medicaid claims is the second. Unsupported diagnosis – where the ICD-10 code on the claim does not match an indication covered by the payer’s policy for J0561 – is the third. For practices building systematic healthcare compliance processes, J0561 documentation requirements fit naturally into a broader drug administration audit framework.

Practices running high volumes of injectable antibiotic billing can benefit from automated claim scrubbing that flags unit calculation mismatches before submission. Pabau’s claims management tools support structured documentation workflows that reduce the risk of these preventable denials reaching the payer. For related billing reference content, the CPT code billing guides on Pabau follow the same documentation-first approach.

Reduce J-code billing errors before they reach the payer

Pabau helps practices manage drug administration documentation, track billing unit calculations, and submit cleaner claims across Medicare and Medicaid. See how it works for your clinic.

Book a demo

Streamlining J0561 billing in practice

For clinics that regularly administer penicillin G benzathine injections – sexual health practices, public health departments, family medicine clinics, and infectious disease providers – billing efficiency depends on standardizing the documentation-to-claim workflow. The three most common failure points are all preventable: unit miscalculation, missing NDC, and unsupported diagnosis code.

Building a J0561-specific drug administration template into the clinical workflow captures the dose in units, the NDC, and the ICD-10 code at the point of care. That data flows directly into the claim, eliminating the reconstruction step that produces most errors. Pabau’s digital clinical forms can be configured to capture this data in a structured format for every injectable drug administration visit. Practices interested in broader practice management software approaches to billing documentation will find the same structured-capture logic applies across all J-code drug billing scenarios.

The PGM Billing free HCPCS lookup tool provides quick access to the official code descriptor, effective dates, and related code cross-references for J0561 and adjacent codes. For quarterly rate verification, the CMS Physician Fee Schedule lookup is the authoritative source for current Medicare Part B payment allowables.

Conclusion

Unit calculation errors and missing NDCs account for the majority of avoidable J0561 claim failures. Solving both is a documentation problem, not a coding problem: capture the dose in units, the product NDC, and the ICD-10 diagnosis at the point of care, and the claim almost writes itself correctly.

Pabau’s claims management software helps injectable drug practices build these documentation standards into every visit, reducing denials before they reach the payer. See how it works for your clinic – explore related billing reference guides or book a demo to see Pabau’s billing workflow in action.

Continue your research

Need a framework for injectable drug compliance documentation? Structured medical forms for healthcare practices covers how to build documentation templates that capture the clinical data your billing team needs.

Billing across a sexual health or primary care clinic? Sexual health clinic software from Pabau supports the full visit workflow from intake to claim for clinics with high J-code injection volumes.

Want to understand compliance requirements for medical practices? HIPAA compliance for medical offices outlines the documentation and security standards that protect your practice during payer audits.

Frequently Asked Questions